Nasdaq · CIK 0001779372
BEATW HeartBeam, Inc.
Insider trading from SEC Form 4. Last filing 4 d ago. Close $0.01 on Oct 9, 2026, 0% from the 52-week low and 0% from the high.
HeartBeam, Inc. (BEATW) has 38 SEC Form 4 filings on file from 11 insiders, the latest filed on Oct 9, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
8 open-market trades have been scored at BEATW. The newest: Tim Cruickshank (CFO) bought $25k of stock on Apr 16, 2026, filed Apr 16, 2026, scored 52 (moderate). The largest of the 8 shown: Mark E Strome (10% owner) sold $895k on Dec 17, 2025, scored 44 (moderate). 4 insiders bought within 14 days of each other around Apr 16, 2026.
BEATW closed at $0.01 on Oct 9, 2026, 0% above its 52-week low and at a 52-week high.
Last 90 days
Signals
Open-market buys and sells at HeartBeam, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 52Moderate | Tim Cruickshank CFO buy | $25k 31,250 shares | +76% | - | |
| 45Moderate | Robert Paul ENO President buy | $10k 12,500 shares | +52% | - | |
| 51Moderate | Willem Elfrink director buy | $150k 187,500 shares | +53% | - | |
| 43Moderate | Richard Ferrari director buy | $50k 62,500 shares | +27% | - | |
| 44Moderate | Mark E Strome owner sell | $895k 250,000 shares | -8% | - | |
| 55Moderate | George de Urioste director sell | $182k 57,146 shares | -100% | - | |
| 43Moderate | Tim Cruickshank CFO buy | $30k 17,647 shares | - | - | |
| 33Weak | Richard Ferrari director buy | $50k 29,412 shares | +20% | - |
Transactions
Every row filed, 37 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | Willem Elfrink director | AGrant or award Restricted Stock Unitsderivative | +93,750 | $0.00 | $0 | 93,750 | 4 d ago |
| Oct 2, 2026 | Richard Ferrari director | AGrant or award Restricted Stock Unitsderivative | +125,000 | $0.00 | $0 | 125,000 | 4 d ago |
| Oct 2, 2026 | Michael R Jaff director | AGrant or award Restricted Stock Unitsderivative | +93,750 | $0.00 | $0 | 93,750 | 4 d ago |
| Oct 2, 2026 | George de Urioste director | AGrant or award Restricted Stock Unitsderivative | +93,750 | $0.00 | $0 | 93,750 | 4 d ago |
| Oct 2, 2026 | Kenneth Warwick Nelson III director | AGrant or award Restricted Stock Unitsderivative | +93,750 | $0.00 | $0 | 93,750 | 4 d ago |
| Oct 2, 2026 | Marga Ortigas-Wedekind director | AGrant or award Restricted Stock Unitsderivative | +93,750 | $0.00 | $0 | 93,750 | 4 d ago |
| Oct 2, 2026 | Willem Elfrink director | AGrant or award Stock Option (right to buy)derivative | +93,750 | $0.00 | $0 | 93,750 | 4 d ago |
| Oct 2, 2026 | Michael R Jaff director | AGrant or award Restricted Stock Unitsderivative | +37,500 | $0.00 | $0 | 37,500 | 4 d ago |
| Oct 2, 2026 | Marga Ortigas-Wedekind director | AGrant or award Stock Option (right to buy)derivative | +81,250 | $0.00 | $0 | 81,250 | 4 d ago |
| Oct 2, 2026 | Kenneth Warwick Nelson III director | AGrant or award Restricted Stock Unitsderivative | +31,250 | $0.00 | $0 | 31,250 | 4 d ago |
| Oct 2, 2026 | George de Urioste director | AGrant or award Stock Option (Right to Buy)derivative | +93,750 | $0.00 | $0 | 93,750 | 4 d ago |
| Oct 2, 2026 | Richard Ferrari director | AGrant or award Restricted Stock Unitsderivative | +90,625 | $0.00 | $0 | 90,625 | 4 d ago |
| Oct 2, 2026 | Richard Ferrari director | AGrant or award Stock Option (Right to Buy)derivative | +125,000 | $0.00 | $0 | 125,000 | 4 d ago |
| Apr 16, 2026 | Tim Cruickshank CFO | POpen-market purchase Common Stock | +31,250 | $0.80 | $25k | 72,230 | Apr 16, 2026 |
| Apr 16, 2026 | Robert Paul ENO President | POpen-market purchase Common Stock | +12,500 | $0.80 | $10k | 36,742 | Apr 16, 2026 |
| Apr 16, 2026 | Willem Elfrink director | POpen-market purchase Common Stock | +187,500 | $0.80 | $150k | 538,667 | Apr 16, 2026 |
| Apr 16, 2026 | Richard Ferrari director | POpen-market purchase Common Stock | +62,500 | $0.80 | $50k | 291,636 | Apr 16, 2026 |
| Feb 9, 2026 | Marga Ortigas-Wedekind director | AGrant or award Common Stock(right to buy)derivative | +44,827 | $0.00 | $0 | 44,827 | Mar 23, 2026 |
| Feb 9, 2026 | Robert Paul ENO President | AGrant or award Common Stock (right to buy)derivative | +55,172 | $0.00 | $0 | 55,172 | Mar 23, 2026 |
| Feb 9, 2026 | Mark E Strome owner | AGrant or award Common Stock (right to buy)derivative | +41,380 | $0.00 | $0 | 41,380 | Mar 23, 2026 |
| Feb 9, 2026 | Michael R Jaff director | AGrant or award Common Stock | +20,689 | $0.00 | $0 | 95,809 | Mar 23, 2026 |
| Feb 9, 2026 | Branislav Vajdic President | AGrant or award Common Stock (right to buy)derivative | +61,932 | $0.00 | $0 | 61,932 | Mar 23, 2026 |
| Feb 9, 2026 | Kenneth Warwick Nelson III director | AGrant or award Common Stock | +17,241 | $0.00 | $0 | 144,388 | Mar 23, 2026 |
| Feb 9, 2026 | George de Urioste director | AGrant or award Common Stock (right to buy)derivative | +51,724 | $0.00 | $0 | 51,724 | Mar 23, 2026 |
| Feb 9, 2026 | Richard Ferrari director | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 229,136 | Mar 23, 2026 |
| Feb 9, 2026 | Willem Elfrink director | AGrant or award Common Stock (right to buy)derivative | +51,724 | $0.00 | $0 | 51,724 | Mar 23, 2026 |
| Feb 9, 2026 | Tim Cruickshank CFO | AGrant or award Common Stock (right to buy)derivative | +53,104 | $0.00 | $0 | 53,104 | Mar 23, 2026 |
| Dec 17, 2025 | Mark E Strome owner | SOpen-market sale Common Stockindirect: See Footnote | -250,000 | $3.58 | $895k | 2,900,000 | Dec 22, 2025 |
| Dec 17, 2025 | George de Urioste director | SOpen-market sale Common Stock | -23,961 | $3.68 | $88k | 33,185 | Dec 19, 2025 |
| Dec 18, 2025 | George de Urioste director | SOpen-market sale Common Stock | -33,185 | $2.83 | $94k | 0 | Dec 19, 2025 |
| Apr 7, 2025 | Tim Cruickshank Chief Financial Officer | AGrant or award Common Stock (right to buy)derivative | +150,000 | $0.00 | $0 | 550,000 | May 1, 2025 |
| Apr 7, 2025 | Robert Paul ENO Chief Executive Officer | AGrant or award Stock option (right to buy)derivative | +320,000 | $0.00 | $0 | 856,000 | May 1, 2025 |
| Apr 7, 2025 | Branislav Vajdic President | AGrant or award Stock option (right to buy)derivative | +180,000 | $0.00 | $0 | 1,374,000 | May 1, 2025 |
| Apr 7, 2025 | Kenneth Harry Persen Chief Technology Officer | AGrant or award Stock option (right to buy)derivative | +20,000 | $0.00 | $0 | 441,000 | May 1, 2025 |
| Feb 14, 2025 | Tim Cruickshank CFO | POpen-market purchase Common Stock | +17,647 | $1.70 | $30k | 17,647 | Feb 21, 2025 |
| Feb 14, 2025 | Richard Ferrari director | POpen-market purchase Common Stock | +29,412 | $1.70 | $50k | 179,136 | Feb 21, 2025 |
| Sep 25, 2024 | Tim Cruickshank CFO | AGrant or award Common Stock (right to buy)derivative | +400,000 | $2.28 | $912k | 400,000 | Feb 21, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Tim CruickshankCFO
- Robert Paul ENOPresident
- Willem Elfrinkdirector
- Richard Ferraridirector
- Michael R Jaffdirector
- Kenneth Warwick Nelson IIIdirector
- Marga Ortigas-Wedekinddirector
- Kenneth Harry PersenChief Technology Officer
- Mark E Stromeowner
- Branislav VajdicPresident
- George de Uriostedirector
Questions about BEATW
Answered from the filings on this page, as of the latest one.
Are insiders buying BEATW?
No. In the last 90 days no insider at HeartBeam, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade BEATW on the open market?
Tim Cruickshank (CFO) bought $25k of BEATW on Apr 16, 2026 and filed the Form 4 on Apr 16, 2026. InsiderTell scored 52 (moderate), with 4 insiders on the same side within 14 days.
How many insiders file Form 4 at HeartBeam, Inc.?
11 people have filed a Form 4 at HeartBeam, Inc., among them Tim Cruickshank (CFO), Robert Paul ENO (President), Willem Elfrink (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.